Compare QNRX & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNRX | AIXI |
|---|---|---|
| Founded | 2018 | 2001 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 8.9M |
| IPO Year | N/A | 2023 |
| Metric | QNRX | AIXI |
|---|---|---|
| Price | $12.25 | $0.62 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 154.3K | ★ 194.5K |
| Earning Date | 11-06-2025 | 12-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $70,314,315.00 |
| Revenue This Year | N/A | $26.84 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.84 |
| 52 Week Low | $5.01 | $0.60 |
| 52 Week High | $41.80 | $6.65 |
| Indicator | QNRX | AIXI |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 34.99 |
| Support Level | $11.48 | $0.64 |
| Resistance Level | $15.45 | $0.71 |
| Average True Range (ATR) | 2.60 | 0.08 |
| MACD | -1.05 | 0.01 |
| Stochastic Oscillator | 11.54 | 7.92 |
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.